Haptoglobin phenotype, angiogenic factors, and preeclampsia risk

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 4, 2012, Pages 358.e10-358.e18

  Weissgerber, Tracey L ^a,d   Roberts, James M ^a,b,d   Jeyabalan, Arun ^a   Powers, Robert W ^a   Lee, Minjae ^a,d   Datwyler, Saul A ^e   Gandley, Robin E ^a,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e ABBOTT LABORATORIES   (United States)

Author keywords

angiogenesis; gestational hypertension; haptoglobin phenotype; preeclampsia

Indexed keywords

ANGIOGENIC FACTOR; ENDOGLIN; FMS LIKE TYROSINE KINASE 1; HAPTOGLOBIN; HEMOGLOBIN; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREECLAMPSIA; PREGNANCY; PRIMIPARA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 84862814752     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.01.009     Document Type: Article

References (23)

1. Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension; Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000;95:24-8. (Pubitemid 30001623)
2. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynaecol Obstet 1998;61:127-33. (Pubitemid 28221417)
3. World Health Organization. World health report: make every mother and child count. Geneva: World Health Organization; 2005.
4. Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomized placebo-controlled trial. Lancet 2002;359:1877-90. (Pubitemid 34615765)
5. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia. J Clin Invest 2003;111:649-58.
6. Chappell LC, Seed PT, Briley A, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127-36. (Pubitemid 34800311)
7. Levy AP, Asleh R, Blum S, et al. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010;12:293-304.
8. Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996;42:1589-600. (Pubitemid 26354735)
9. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-85. (Pubitemid 23095272)
10. Levy AP, Friedenberg P, Lotan R, et al. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women. Diabetes Care 2004;27:925-30. (Pubitemid 38420216)
11. Milman U, Blum S, Shapira C, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective doubleblinded clinical trial. Arterioscler Thromb Vasc Biol 2008;28:341-7. (Pubitemid 351161209)
12. Depypere HT, Langlois MR, Delanghe JR, Temmerman M, Dhont M. Haptoglobin polymorphism in patients with preeclampsia. Clin Chem Lab Med 2006;44:924-8. (Pubitemid 44155858)
13. Raijmakers MT, Roes EM, te Morsche RH, Steegers EA, Peters WH. Haptoglobin and its association with the HELLP syndrome. J Med Genet 2003;40:214-6. (Pubitemid 36315395)
14. Sammour RN, Nakhoul FM, Levy AP, et al. Haptoglobin phenotype in women with preeclampsia. Endocrine 2010;38:303-8.
15. Lind T, Godfrey KA, Otun H, Philips PR. Changes in serum uric acid concentrations during normal pregnancy. Br J Obstet Gynaecol 1984;91:128-32. (Pubitemid 14181944)
16. Roberts JM, Bodnar LM, Lain KY, et al. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005;46:1263-9. (Pubitemid 43189721)
17. Hochberg I, Roguin A, Nikolsky E, Chanderashekhar PV, Cohen S, Levy AP. Haptoglobin phenotype and coronary artery collaterals in diabetic patients. Atherosclerosis 2002;161:441-6. (Pubitemid 34219199)
18. Kapralov A, Vlasova II, Feng W, et al. Peroxidase activity of hemoglobin-haptoglobin complexes: covalent aggregation and oxidative stress in plasma and macrophages. J Biol Chem 2009;284:30395-407.
19. Powers RW, Roberts JM, Plymire DA, et al. Low PLGF across pregnancy identifies a set of women with preterm preeclampsia and small for gestational age infants. Reprod Sci 2010;17:132A.
20. Carter K, Worwood M. Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol 2007;29:92-110. (Pubitemid 46911165)
21. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010; 122:478-87.
22. Mekbeb T. The association of serum proteins with preeclampsia. Ethiop Med J 1990; 28:9-14.
23. Napolioni V. Regarding "haptoglobin 2-1 phenotype predicts rapid growth of abdominal aortic aneurysms". J Vasc Surg 2011;53:266-7.